Principal Investigator
Marijo Bilusic
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20241219
Clinical Trial Summary
GUARDIAN-101: A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY OF CLSP-1025 IN ADULT PATIENTS WITH SOLID TUMORS THAT HARBOR THE P53 R175H MUTATION
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Prostate, Bladder, and Kidney Cancers
Contact Information
Phone Number
+1 (954) 8177628